Cargando…
Correction: Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594516/ https://www.ncbi.nlm.nih.gov/pubmed/36270764 http://dx.doi.org/10.1136/bmjopen-2019-029101corr1 |
Ejemplares similares
-
Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
por: Klumper, Job, et al.
Publicado: (2019) -
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)
por: van Vliet, Elvira OG, et al.
Publicado: (2014) -
Effects of tocolysis with nifedipine or atosiban on child outcome: follow‐up of the APOSTEL III trial
por: van Winden, TMS, et al.
Publicado: (2020) -
Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth
por: Grzesiak, Mariusz, et al.
Publicado: (2018) -
Management of preterm labor: atosiban or nifedipine?
por: de Heus, Roel, et al.
Publicado: (2010)